Patrick Pauwels
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Patrick Pauwels has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alain Bols
Department of Oncology, AZ Sint-Jan Brugge, Ruddershove 10, 8000 Bruges, Belgium
1 shared publication - Filip J. Baert
Gastroenterology, H. Hartziekenhuis, Roeselaere, Belgium
1 shared publication - Frank Speleman
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
1 shared publication - Jean-Luc Van Laethem
Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium
1 shared publication - Jo Van Dorpe
Department of Pathology, Heilig Hart Ziekenhuis Roeselare, Wilgenstraat 2, 8800 Roeselare, Belgium
1 shared publication - Marc Peeters
Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk, Belgium
1 shared publication
Latest Publications
- Open Access
- 11 May 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 189
Epidermal Growth Factor Receptor and K-RAS status in two cohorts of squamous cell carcinomas
With the availability of effective anti-EGFR therapies for various solid malignancies, such as non-cell small lung cancer, colorectal cancer and squamous cell carcinoma of the head and neck, the knowledge of EGFR and K-RAS status becomes clinically important. The aim of this study was to analyse EGFR expression, EGFR gene copy number and EGFR and K-RAS mutations in two cohorts of squamous cell carcinomas, specifically anal canal and tonsil carcinomas.
- 11 May 2010
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 189
Open AccessEpidermal Growth Factor Receptor and K-RAS status in two cohorts of squamous cell carcinomas
With the availability of effective anti-EGFR therapies for various solid malignancies, such as non-cell small lung cancer, colorectal cancer and squamous cell carcinoma of the head and neck, the knowledge of EGFR and K-RAS status becomes clinically important. The aim of this study was to analyse EGFR expression, EGFR gene copy number and EGFR and K-RAS mutations in two cohorts of squamous cell carcinomas, specifically anal canal and tonsil carcinomas.